Cardiome (CRME) Announces That Collaboration and License Agreement with Merck & Co. (MRK)
Tweet Send to a Friend
Cardiome Pharma Corp. (NASDAQ: CRME) announced that the waiting period under the Hart-Scott-Rodino Act for the collaboration and license agreement ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
